Citigroup’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.38K Buy
629
+361
+135% +$2.8K ﹤0.01% 5290
2025
Q4
$1.89K Sell
268
-116
-30% -$895 ﹤0.01% 5463
2025
Q3
$2.86K Sell
384
-5,553
-94% -$42.2K ﹤0.01% 5398
2025
Q2
$43.6K Buy
5,937
+1,084
+22% +$9.46K ﹤0.01% 4839
2025
Q1
$37.5K Sell
4,853
-546
-10% -$5.99K ﹤0.01% 4957
2024
Q4
$65.3K Buy
5,399
+323
+6% +$4.13K ﹤0.01% 5007
2024
Q3
$63.7K Buy
5,076
+3,514
+225% +$45.3K ﹤0.01% 4941
2024
Q2
$18.6K Sell
1,562
-10,606
-87% -$146K ﹤0.01% 5024
2024
Q1
$213K Buy
12,168
+4,420
+57% +$79.7K ﹤0.01% 3999
2023
Q4
$199K Buy
+7,748
New +$110K ﹤0.01% 3924
2022
Q3
Sell
-67
Closed -$1K 6034
2022
Q2
$1K Buy
+67
New +$445 ﹤0.01% 6027
2021
Q2
Sell
-649
Closed -$25K 6243
2021
Q1
$25K Sell
649
-280
-30% -$12.8K ﹤0.01% 5106
2020
Q4
$44K Buy
929
+788
+559% +$34.1K ﹤0.01% 6125
2020
Q3
$5K Sell
141
-165
-54% -$6.46K ﹤0.01% 7014
2020
Q2
$13K Buy
+306
New +$14.4K ﹤0.01% 6907
2019
Q4
Sell
-179
Closed -$7K 7727
2019
Q3
$7K Sell
179
-591
-77% -$31.9K ﹤0.01% 7212
2019
Q2
$43K Buy
770
+378
+96% +$23.6K ﹤0.01% 6607
2019
Q1
$24K Sell
392
-69
-15% -$4.43K ﹤0.01% 6855
2018
Q4
$28K Buy
461
+26
+6% +$1.92K ﹤0.01% 6682
2018
Q3
$35K Buy
435
+118
+37% +$9.35K ﹤0.01% 6796
2018
Q2
$28K Buy
+317
New +$55.6K ﹤0.01% 6737
2017
Q1
Sell
-1
Closed 7245
2016
Q4
$0 Buy
+1
New +$90 ﹤0.01% 7237
2016
Q1
Sell
-1
Closed 7565
2015
Q4
$0 Buy
+1
New +$393 ﹤0.01% 7674
2015
Q1
Sell
-1
Closed -$2K 7280
2014
Q4
$2K Buy
+1
New +$1.93K ﹤0.01% 6861
2014
Q3
Sell
-2
Closed -$4.95K 6906
2014
Q2
$5K Sell
2
-4
-67% -$13.1K ﹤0.01% 6457
2014
Q1
$21K Sell
6
-10
-63% -$37K ﹤0.01% 5990
2013
Q4
$51K Buy
16
+1
+7% +$3.94K ﹤0.01% 5715
2013
Q3
$61K Sell
15
-1
-6% -$4.02K ﹤0.01% 5126
2013
Q2
$53K Buy
+16
New +$60.9K ﹤0.01% 5342

Other funds holding GYRE